Table 3.
Type of Cancer | Animal Models | Mechanisms | Dosage | Duration | References |
---|---|---|---|---|---|
Hepatocellular | Chemically induced HCC rat model with injection of Diethylnitrosamine @200 mg/kg | ↓ Liver enzymes—aminotransferase (ALT), ↓ aspartate aminotransferase (AST), ↓ alkaline phosphatase (ALP), ↓ total proteins (TP) and conjugated bilirubin (direct bilirubin), ↓ C-reactive protein (CRP), ↓ interleukin 6 (IL-6), ↓ lactate dehydrogenase (LDH), ↓ PIVKA-II and AFP, ↓ Ki-67 cells, ↓ TNFa, VEGF, p53 and NF-κB expression | Quercetin 50 mg/kg + sorafenib 7.5 mg/kg | 13 weeks | [78] |
Hepatoblastoma | BALB/c nude mice bearing HepG2 cells (1 × 107) cells | ↓ Tumors grew slower and size, ↓ weighed, ↑ SIRT6, ↓ FZD4 | 10 mg/kg | 28 days | [78] |
Hepatocellular | BALB/c nude mice bearing SMMC7721 cells (2 × 106) cells | ↑ Autophagosomes and autolysosomes, ↓ AKT/mTOR, ↑ MAPK, ↑cleaved caspase-3, ↑ BAX, ↓ Bcl-2, ↑ LC3A/B, ↓ p62, ↑ necrosis | 60 mg/kg | 10 days | [48] |
Hepatocellular | Sprague Dawley rats (TAA Induced) | ↓ Caspase-3, ↓↑ caspase-8, ↑ p53, ↓ cyclin D1 and Ki-67 | TAA -200 mg/kg + Quercetin 100 mg/kg | 21 days | [29] |
Hepatocellular | Nude mice bearing LM3 cells |
↓ Tumor volume, ↑ necrosis, ↑ TUNEL-positive cells, ↓ PCNA, ↑ Bax | 100 mg/kg | 21 days | [32] |
Hepatocellular | BALB/c nu/nu nude mice bearing MHCC97H cells (1 × 107 cells) | ↓ Tumor volumes, ↓ AP-2β and COX2 levels, ↑ TUNEL levels, ↓ cleaved caspase-9, ↓ cleaved caspase-3, ↓ cytoplasm Cyto-c, ↓ phosphorylated IKKα, IκBα and NF-κB | 30, 40 and 50 mg/kg Quercetin nanoparticles | 35 days | [49] |
Hepatocellular | BALB/C nude mice bearing HuH-cells | ↓ Tumor volume, ↑ survival rate | ZD55-TRAIL was injected intra-tumorally at 1 × 109 plaque-forming units + Quercetin 150 mg/kg |
49 days | [79] |
Hepatocellular | BALB/c nude mice |
↑ 5-fluorouracil (5-FU) therapeutic efficacy, ↑ apoptosis, ↓ tumor growth | Quercetin 40 mg/kg and 5-fluorouracil 30 mg/kg |
23 days | [28] |
Liver | Wistar rats (two-phase model of hepato carcinogenesis) | ↓ Number and volume of preneoplastic lesions, ↑ apoptosis, ↓ proliferative index, ↓ cell percentages ↓ M phase, ↓ cyclin D1, ↓ cyclin A, ↓ cyclin B, ↓ cyclin-dependent kinase 1, ↑ peroxisome proliferator, ↑ caspase-3 activity, ↑ Bax/Bcl-2, ↑ cytosolic cytochrome c | 10 and 20 mg/kg | 42 days | [27] |
Hepatoma | C57BL/6N mice bearing LL/2 Lewis lung cancer (1 × 106) | ↓ Tumor growth, ↓ tumor volume, ↓ HSP70, ↑ apoptosis rate | Liposomal Quercetin -50 mg/kg | 15 days | [103] |
Hepatoma | BALB/c mice bearing H22 tumor models (5 × 105) | ↓ Tumor growth, ↓ tumor volume, ↓ HSP70, ↑ apoptosis rate | Liposomal Quercetin -50 mg/kg | 15 days | [103] |